2-Bromo-4-fluoro-6-methylaniline, 95.0%, 500g

2,4,6-Trifluoro-1-(methoxymethoxy)benzene, 98%, 1g

3-Bromo-2,2-dimethoxy-propionic acid methyl ester, 90.0%, 1g

Laevulinic acid, min. 98%, for synthesis, 50 g, glass packaging

4-(Trifluoromethyl)thiobenzamide, 97.0%, 25g

3-([1,1'-Biphenyl]-4-yl)propiolic acid, 95%, 250mg

2,7-Bis[N-(m-tolyl)anilino]-9,9'-spirobi[9H-fluorene]>98.0%(HPLC)(N)200mg

(S)-3-Methyl-1-(2-piperidin-1-yl-phenyl)butylamine, 98.0%, 5g

Ethyl 3-(2-bromophenyl)acrylate, 95+%, 5g

methyl S-methyl-L-cysteinate hydrochloride, 95.0%, 10g

Glass syringe Dosys with Luer connection (glass), 20 ml, 2 pieces

tert-Butyl 2-(2-aminoethyl)-2,7-diazaspiro[3.5]nonane-7-carboxylate dihydrochloride, 97%, 1g

3-(Difluoromethoxy)iodobenzene, 95.0%, 25g